The Vanderbilt-lngram Cancer Center (VICC) is requesting partial salary support for five research staff investigators and two clinical staff investigators. These individuals provide important leadership in areas critical to the VICC mission and strategic initiatives. Six of the staff investigators do not have a leadership position within the CCSG research programs or shared resources, with the exception being Jordan Berlin, M.D.. Support for Dr. Beriin is requested in recognition of his role as leader of VICC Phase I Investigations and his contributions in all facets of clinical investigation, which are distinct from his other CCSG responsibilities. The remaining staff investigators are: John Gore, Ph.D., Director of the Vanderbilt Institute of Imaging Science, for collaborations with VICC towards the expansion of cancer imaging and application of imaging biomarks in non-invasive targeted cancer treatments;Daniel Liebler, Ph.D., Director of the Jim Ayers Institute for Precancer Detection and Diagnosis, for providing critical trans-disciplinary collaborations throughout VICC involving proteomic-based discoveries and technology platforms;Lawrence Marnett, Ph.D., Director of the Vanderbilt Institute of Chemical Biology, for collaborative initiatives in the area of cancer drug discovery and the application of chemical technologies towards the detection, prevention and treatment of cancer;Harold Moses, M.D., Interim Chair of Cancer Biology and VICC Director Emeritus, for his continuing contributions to VICC, including membership on the Executive Committee and Research Program Leaders Committee, as well as national leadership positions (Institute of Medicine, American Association for Cancer Research and Association of American Cancer Institutes, etc.) that facilitate the VICC's ability to maximize opportunities in emerging areas of cancer-relevant research or policy;William Pao, M.D., Assistant Director of VICC Personalized Cancer Medicine, for collaborative efforts towards development of a platform that will expand routine genetic testing of tumors from VUMC patients and disseminate results seamlessly to practicing oncologists;and Igor Puzanov, M.D., Associate Director of Phase I investigations, for development of investigator-initiated trials using preclinical data generated from the seven CCSG research programs and interactions with investigators involved in the VICC cancer drug discovery initiative.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-17
Application #
8544998
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
17
Fiscal Year
2013
Total Cost
$135,534
Indirect Cost
$86,081
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Phelps, Hannah M; Al-Jadiry, Mazin F; Corbitt, Natasha M et al. (2018) Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. World J Pediatr 14:585-593
Liu, Qi; Herring, Charles A; Sheng, Quanhu et al. (2018) Quantitative assessment of cell population diversity in single-cell landscapes. PLoS Biol 16:e2006687
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Greenplate, Allison; Wang, Kai; Tripathi, Rati M et al. (2018) Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies. JCO Precis Oncol 2018:
Mi, Deborah J; Dixit, Shilpy; Warner, Timothy A et al. (2018) Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice. Neurobiol Aging 71:241-254
Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123
Warner, Jeremy L; Prasad, Ishaan; Bennett, Makiah et al. (2018) SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine. JCO Precis Oncol 2018:
Brown, Judy J; Short, Sarah P; Stencel-Baerenwald, Jennifer et al. (2018) Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection. J Virol 92:
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543
Diggins, Kirsten E; Gandelman, Jocelyn S; Roe, Caroline E et al. (2018) Generating Quantitative Cell Identity Labels with Marker Enrichment Modeling (MEM). Curr Protoc Cytom 83:10.21.1-10.21.28

Showing the most recent 10 out of 2462 publications